DATA GRAPHICS | Regulation
Data Bytes: CHMP’s June opinions
June 26, 2020 11:59 PM UTC
A recommendation by EMA’s CHMP suggests remdesivir from Gilead Sciences Inc. (NASDAQ:GILD) could soon gain a speedy conditional approval to treat COVID-19. The committee announced the decision this w...